Anne Martina Maria Loohuis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anne Martina Maria Loohuis has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Marcus Hendrikus Blanker
Department of Primary and Long‐term Care University of Groningen, University Medical Center Groningen Groningen The Netherlands
15 shared publications - Nienke J. Wessels
Department of General Practice and Elderly Care Medicine University Medical Centre Groningen, University of Groningen Groningen The Netherlands
9 shared publications - Henk van der Worp
Department of Primary and Long-term Care, Cure and Care in the Community Context (FOUR-C) research program, University of Groningen, University Medical Center Groningen, Groningen, Netherlands
8 shared publications Henk van der Worp
Department of Primary and Long-Term Care, Cure and Care in the Community Context (FOUR-C)- Research Program, University Medical Center Groningen, University of Groningen , PO box 196, 9700 AD Groningen
7 shared publications- Janny Hendrika Dekker
Department of General Practice and Elderly Care Medicine, University Medical Center Groningen University of Groningen Groningen The Netherlands
5 shared publications - Lisette van Gemert-Pijnen
Centre for eHealth and Wellbeing Research, Section of Psychology, Health and Technology, University of Twente, Enschede, The Netherlands
5 shared publications
Latest Publications
- 6 October 2026
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 43 (6)
Implementation of an evidence-based app to improve healthcare for female urinary incontinence: identification of implementation strategies using the consolidated framework for implementation research-expert recommendations for implementation change matching tool
Background: Female urinary incontinence (UI) affects one in three women and is frequently managed suboptimally. The app-based treatment URinControl demonstrated cost-effectiveness. However, implementation in Dutch primary care is limited. This study aimed to identify key barriers to implementation and develop strategies to support the uptake of URinControl in primary care settings. Methods: We conducted a cross-sectional survey among Dutch general practitioners (GPs), community pharmacists, and supporting personnel working in general practice or local pharmacies. Barriers were identified using the Consolidated Framework for Implementation Research (CFIR). Potential implementation strategies were selected using the CFIR–Expert Recommendations for Implementing Change (ERIC) matching tool. Results: A total of 174 healthcare professionals completed the questionnaire. Key barriers from both GP and pharmacy perspectives included doubts about the relative advantage of the app, limited knowledge of urinary incontinence and the app, organizational constraints, and limited digital skills among patients. In pharmacies, additional barriers included limited opportunity to discuss UI and concerns about financing. Based on these findings, five implementation strategies were developed. Interpretation: Effective implementation of an evidence-based digital app for urinary incontinence in primary care requires improved awareness, knowledge, and support for healthcare professionals, as well as better structural integration of digital health tools into routine practice. Broader policy and societal shifts toward acceptance of eHealth are also needed. We also translated barriers into five tailored, theory-informed strategies addressing clinician education, patient engagement, workflow integration, financing, and collaboration between general practice and community pharmacy settings across the Netherlands in routine care implementation.
- 6 October 2026
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 43 (6)
Implementation of an evidence-based app to improve healthcare for female urinary incontinence: identification of implementation strategies using the consolidated framework for implementation research-expert recommendations for implementation change matching tool
Background: Female urinary incontinence (UI) affects one in three women and is frequently managed suboptimally. The app-based treatment URinControl demonstrated cost-effectiveness. However, implementation in Dutch primary care is limited. This study aimed to identify key barriers to implementation and develop strategies to support the uptake of URinControl in primary care settings. Methods: We conducted a cross-sectional survey among Dutch general practitioners (GPs), community pharmacists, and supporting personnel working in general practice or local pharmacies. Barriers were identified using the Consolidated Framework for Implementation Research (CFIR). Potential implementation strategies were selected using the CFIR–Expert Recommendations for Implementing Change (ERIC) matching tool. Results: A total of 174 healthcare professionals completed the questionnaire. Key barriers from both GP and pharmacy perspectives included doubts about the relative advantage of the app, limited knowledge of urinary incontinence and the app, organizational constraints, and limited digital skills among patients. In pharmacies, additional barriers included limited opportunity to discuss UI and concerns about financing. Based on these findings, five implementation strategies were developed. Interpretation: Effective implementation of an evidence-based digital app for urinary incontinence in primary care requires improved awareness, knowledge, and support for healthcare professionals, as well as better structural integration of digital health tools into routine practice. Broader policy and societal shifts toward acceptance of eHealth are also needed. We also translated barriers into five tailored, theory-informed strategies addressing clinician education, patient engagement, workflow integration, financing, and collaboration between general practice and community pharmacy settings across the Netherlands in routine care implementation.
- Open Access
- 22 June 2026
- Published by Elsevier in SSRN Electronic Journal
AI Scribe technology improves efficiency of consultations in Dutch Primary Care: A real-world observational pre-post study
BackgroundAdministrative burden contributes substantially to workload and burnout in primary care. AI-based voice-to-note tools (“AI scribes”) may reduce documentation time, but real-world evidence in primary care remains limited. We evaluated the impact of a Dutch-language AI scribe on consultation efficiency in routine primary care. MethodsWe conducted a prospective pre–post pilot study between December, 2024, and May, 2025, in 16 general practices in the province of Drenthe, the Netherlands. General practitioners (GPs) and nurse practitioners (NPs) registered 20 consecutive consultations before and after implementation of an AI scribe integrated with their electronic health record system. The primary outcome was the difference in the proportion of consultation time spent on administration (percentage points, 95% CI). Secondary outcomes were total consultation duration (seconds), administrative time (seconds), and number of clinical issues addressed. Linear mixed-effects models accounted for clustering within clinicians and practices. FindingsNineteen clinicians (14 GPs, five NPs) contributed 719 consultations (379 pre-use; 340 during use). The proportion of consultation time spent on administration decreased by 9,1 percentage points (95% CI −10,5 to −7,7). Administrative time decreased by 100 seconds (95% CI −116 to −84), and total consultation time decreased by 114 seconds (95% CI −176 to −53). The number of clinical issues addressed per consultation did not change (mean difference −0,02, 95% CI −0,10 to 0,05). Among GPs, administrative time proportion decreased from 27,8% to 17,4% (absolute difference −10,6 percentage points). Effects were independent of age and typing proficiency. InterpretationIn routine Dutch general practice, AI-supported documentation substantially reduced administrative workload and overall consultation time without reducing consultation content. Context-specific integration and evaluation after implementation may be key determinants of effectiveness. Larger controlled studies are needed to assess long-term sustainability, quality, patient experience, and cost-effectiveness. FundingNo commercial funding. The regional GP organisation facilitated participation through discounted access to the technology.
- 22 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAI Scribe technology improves efficiency of consultations in Dutch Primary Care: A real-world observational pre-post study
BackgroundAdministrative burden contributes substantially to workload and burnout in primary care. AI-based voice-to-note tools (“AI scribes”) may reduce documentation time, but real-world evidence in primary care remains limited. We evaluated the impact of a Dutch-language AI scribe on consultation efficiency in routine primary care. MethodsWe conducted a prospective pre–post pilot study between December, 2024, and May, 2025, in 16 general practices in the province of Drenthe, the Netherlands. General practitioners (GPs) and nurse practitioners (NPs) registered 20 consecutive consultations before and after implementation of an AI scribe integrated with their electronic health record system. The primary outcome was the difference in the proportion of consultation time spent on administration (percentage points, 95% CI). Secondary outcomes were total consultation duration (seconds), administrative time (seconds), and number of clinical issues addressed. Linear mixed-effects models accounted for clustering within clinicians and practices. FindingsNineteen clinicians (14 GPs, five NPs) contributed 719 consultations (379 pre-use; 340 during use). The proportion of consultation time spent on administration decreased by 9,1 percentage points (95% CI −10,5 to −7,7). Administrative time decreased by 100 seconds (95% CI −116 to −84), and total consultation time decreased by 114 seconds (95% CI −176 to −53). The number of clinical issues addressed per consultation did not change (mean difference −0,02, 95% CI −0,10 to 0,05). Among GPs, administrative time proportion decreased from 27,8% to 17,4% (absolute difference −10,6 percentage points). Effects were independent of age and typing proficiency. InterpretationIn routine Dutch general practice, AI-supported documentation substantially reduced administrative workload and overall consultation time without reducing consultation content. Context-specific integration and evaluation after implementation may be key determinants of effectiveness. Larger controlled studies are needed to assess long-term sustainability, quality, patient experience, and cost-effectiveness. FundingNo commercial funding. The regional GP organisation facilitated participation through discounted access to the technology.
- Open Access
- 31 March 2026
- Published by Elsevier in SSRN Electronic Journal
AI Scribe Technology Improves Effciency of Consultations in Dutch Primary Care: A Real-world Observational Pre-post Study
Background: Administrative burden contributes substantially to workload and burnout in primary care. AI-based voice-to-note tools (“AI scribes”) may reduce documentation time, but real-world evidence in primary care remains limited. We evaluated the impact of a Dutch-language AI scribe on consultation efficiency in routine primary care. Methods: We conducted a prospective pre–post pilot study between December, 2024, and May, 2025, in 16 general practices in the province of Drenthe, the Netherlands. General practitioners (GPs) and nurse practitioners (NPs) registered 20 consecutive consultations before and after implementation of an AI scribe integrated with their electronic health record system. The primary outcome was the difference in the proportion of consultation time spent on administration (percentage points, 95% CI). Secondary outcomes were total consultation duration (seconds), administrative time (seconds), and number of clinical issues addressed. Linear mixed-effects models accounted for clustering within clinicians and practices. Findings: Nineteen clinicians (14 GPs, five NPs) contributed 719 consultations (379 pre-use; 340 during use). The proportion of consultation time spent on administration decreased by 9,1 percentage points (95% CI −10,5 to −7,7). Administrative time decreased by 100 seconds (95% CI −116 to −84), and total consultation time decreased by 114 seconds (95% CI −176 to −53). The number of clinical issues addressed per consultation did not change (mean difference −0,02, 95% CI −0,10 to 0,05). Among GPs, administrative time proportion decreased from 27,8% to 17,4% (absolute difference −10,6 percentage points). Effects were independent of age and typing proficiency. Interpretation: In routine Dutch general practice, AI-supported documentation substantially reduced administrative workload and overall consultation time without reducing consultation content. Context-specific integration and evaluation after implementation may be key determinants of effectiveness. Larger controlled studies are needed to assess long-term sustainability, quality, patient experience, and cost-effectiveness.
- 31 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessAI Scribe Technology Improves Effciency of Consultations in Dutch Primary Care: A Real-world Observational Pre-post Study
Background: Administrative burden contributes substantially to workload and burnout in primary care. AI-based voice-to-note tools (“AI scribes”) may reduce documentation time, but real-world evidence in primary care remains limited. We evaluated the impact of a Dutch-language AI scribe on consultation efficiency in routine primary care. Methods: We conducted a prospective pre–post pilot study between December, 2024, and May, 2025, in 16 general practices in the province of Drenthe, the Netherlands. General practitioners (GPs) and nurse practitioners (NPs) registered 20 consecutive consultations before and after implementation of an AI scribe integrated with their electronic health record system. The primary outcome was the difference in the proportion of consultation time spent on administration (percentage points, 95% CI). Secondary outcomes were total consultation duration (seconds), administrative time (seconds), and number of clinical issues addressed. Linear mixed-effects models accounted for clustering within clinicians and practices. Findings: Nineteen clinicians (14 GPs, five NPs) contributed 719 consultations (379 pre-use; 340 during use). The proportion of consultation time spent on administration decreased by 9,1 percentage points (95% CI −10,5 to −7,7). Administrative time decreased by 100 seconds (95% CI −116 to −84), and total consultation time decreased by 114 seconds (95% CI −176 to −53). The number of clinical issues addressed per consultation did not change (mean difference −0,02, 95% CI −0,10 to 0,05). Among GPs, administrative time proportion decreased from 27,8% to 17,4% (absolute difference −10,6 percentage points). Effects were independent of age and typing proficiency. Interpretation: In routine Dutch general practice, AI-supported documentation substantially reduced administrative workload and overall consultation time without reducing consultation content. Context-specific integration and evaluation after implementation may be key determinants of effectiveness. Larger controlled studies are needed to assess long-term sustainability, quality, patient experience, and cost-effectiveness.
- Open Access
- 25 March 2026
- Published by Elsevier in SSRN Electronic Journal
Implementation of an Evidence-Based App To Improve Healthcare for Female Urinary Incontinence: Identification of Implementation Strategies Using the CFIR-ERIC Matching Tool
Background: Female urinary incontinence (UI) affects one in three women and is often treated suboptimally. The digital health app URinControl has been shown to be an effective treatment. The implementation of the app in Dutch primary care is lagging. We aimed to identify the main barriers and develop strategies for implementation of URinControl in Dutch primary care. Methods: We performed a survey among Dutch general practitioners (GP), local pharmacists and supporting personnel working in either a general practice or local pharmacy. Barriers were identified using the CFIR Framework. Potential implementation strategies were selected based on the CFIR-ERIC Matching Tool. Findings: 174 health care professionals filled in the questionnaire. The main barriers mentioned from both GP and pharmacy perspective were doubts about the relative advantage of the app, lack of knowledge on UI and the app, organisational aspects, and limited digital abilities of patients. In pharmacies, lack of opportunity to discuss UI and financing were mentioned as well. To facilitate implementation, 5 strategies were developed. Interpretation: Key implementation strategies for an evidence-based app for UI in primary care lie in an increase of awareness, knowledge and support for the individual HCP and a new approach toward digital health-apps from policy and society.
- 25 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessImplementation of an Evidence-Based App To Improve Healthcare for Female Urinary Incontinence: Identification of Implementation Strategies Using the CFIR-ERIC Matching Tool
Background: Female urinary incontinence (UI) affects one in three women and is often treated suboptimally. The digital health app URinControl has been shown to be an effective treatment. The implementation of the app in Dutch primary care is lagging. We aimed to identify the main barriers and develop strategies for implementation of URinControl in Dutch primary care. Methods: We performed a survey among Dutch general practitioners (GP), local pharmacists and supporting personnel working in either a general practice or local pharmacy. Barriers were identified using the CFIR Framework. Potential implementation strategies were selected based on the CFIR-ERIC Matching Tool. Findings: 174 health care professionals filled in the questionnaire. The main barriers mentioned from both GP and pharmacy perspective were doubts about the relative advantage of the app, lack of knowledge on UI and the app, organisational aspects, and limited digital abilities of patients. In pharmacies, lack of opportunity to discuss UI and financing were mentioned as well. To facilitate implementation, 5 strategies were developed. Interpretation: Key implementation strategies for an evidence-based app for UI in primary care lie in an increase of awareness, knowledge and support for the individual HCP and a new approach toward digital health-apps from policy and society.
- Open Access
- 16 March 2026
- Published by Elsevier in Continence Reports
- Vol. 18
Improving the inclusiveness of the URinControl-app for women with low literacy: a teach-back usability study
- 16 March 2026
- Published by Elsevier in Continence Reports
- Vol. 18
Open AccessImproving the inclusiveness of the URinControl-app for women with low literacy: a teach-back usability study
- 21 July 2023
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 73 (suppl 1)
Care provider views on app-based treatment for female urinary incontinence: a mixed-methods study
Background App-based treatment for female urinary incontinence (UI) is a cost-effective alternative to care as usual. For successful implementation it is of major importance to involve stakeholders like care providers. Aim To explore the views and preferences of care providers on app use for the treatment of UI and to identify the anticipated barriers to, and facilitators of, implementation. Method We performed an exploratory, two-phase, sequential mixed-methods study. In phase 1, the views of care providers were explored through five focus group sessions with care providers involved in UI: GPs, practice assistants (PAs), pelvic physical therapists (PPTs), and (uro)gynecologists (UGs). In phase 2, the identified themes and subthemes were quantified in an online survey distributed among different care providers matching these groups. Results In the focus group sessions, 30 female and two male care providers participated. Survey participants included 351 PAs and 76 PPTs (all female) next to 124 GPs and 183 UGs (70% female). Caregivers generally considered UI treatment apps as having a supportive role, being less convinced about their advantages in the absence of a care provider. Additionally, they required that the effectiveness of an app should be proven first, and that privacy and safety should be ensured. Contrasting with other research, lack of time and financial compensation were not considered important barriers to implementation. Conclusion Our results add to the existing knowledge about eHealth-related barriers and facilitators. These findings can be used to optimise implementation strategies for other apps and to enhance the uptake of app-based treatment for UI in the Netherlands.
- 21 July 2023
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 73 (suppl 1)
Care provider views on app-based treatment for female urinary incontinence: a mixed-methods study
Background App-based treatment for female urinary incontinence (UI) is a cost-effective alternative to care as usual. For successful implementation it is of major importance to involve stakeholders like care providers. Aim To explore the views and preferences of care providers on app use for the treatment of UI and to identify the anticipated barriers to, and facilitators of, implementation. Method We performed an exploratory, two-phase, sequential mixed-methods study. In phase 1, the views of care providers were explored through five focus group sessions with care providers involved in UI: GPs, practice assistants (PAs), pelvic physical therapists (PPTs), and (uro)gynecologists (UGs). In phase 2, the identified themes and subthemes were quantified in an online survey distributed among different care providers matching these groups. Results In the focus group sessions, 30 female and two male care providers participated. Survey participants included 351 PAs and 76 PPTs (all female) next to 124 GPs and 183 UGs (70% female). Caregivers generally considered UI treatment apps as having a supportive role, being less convinced about their advantages in the absence of a care provider. Additionally, they required that the effectiveness of an app should be proven first, and that privacy and safety should be ensured. Contrasting with other research, lack of time and financial compensation were not considered important barriers to implementation. Conclusion Our results add to the existing knowledge about eHealth-related barriers and facilitators. These findings can be used to optimise implementation strategies for other apps and to enhance the uptake of app-based treatment for UI in the Netherlands.
- Open Access
- 27 February 2023
- Published by Elsevier in Continence
- Vol. 6
Care provider views on app-based treatment for female urinary incontinence: A mixed-methods study
- 27 February 2023
- Published by Elsevier in Continence
- Vol. 6
Open AccessCare provider views on app-based treatment for female urinary incontinence: A mixed-methods study
- Open Access
Prediction model study focusing on eHealth in the management of urinary incontinence: the Personalised Advantage Index as a decision-making aid
Objective To develop a prediction model and illustrate the practical potential of personalisation of treatment decisions between app-based treatment and care as usual for urinary incontinence (UI). Design A prediction model study using data from a pragmatic, randomised controlled, non-inferiority trial. Setting Dutch primary care from 2015, with social media included from 2017. Enrolment ended on July 2018. Participants Adult women were eligible if they had ≥2 episodes of UI per week, access to mobile apps and wanted treatment. Of the 350 screened women, 262 were eligible and randomised to app-based treatment or care as usual; 195 (74%) attended follow-up. Predictors Literature review and expert opinion identified 13 candidate predictors, categorised into two groups: Prognostic factors (independent of treatment type), such as UI severity, postmenopausal state, vaginal births, general physical health status, pelvic floor muscle function and body mass index; and modifiers (dependent on treatment type), such as age, UI type and duration, impact on quality of life, previous physical therapy, recruitment method and educational level. Main outcome measure Primary outcome was symptom severity after a 4-month follow-up period, measured by the International Consultation on Incontinence Questionnaire the Urinary Incontinence Short Form. Prognostic factors and modifiers were combined into a final prediction model. For each participant, we then predicted treatment outcomes and calculated a Personalised Advantage Index (PAI). Results Baseline UI severity (prognostic) and age, educational level and impact on quality of life (modifiers) independently affected treatment effect of eHealth. The mean PAI was 0.99±0.79 points, being of clinical relevance in 21% of individuals. Applying the PAI also significantly improved treatment outcomes at the group level. Conclusions Personalising treatment choice can support treatment decision making between eHealth and care as usual through the practical application of prediction modelling. Concerning eHealth for UI, this could facilitate the choice between app-based treatment and care as usual. Trial registration number NL4948t.
Open AccessPrediction model study focusing on eHealth in the management of urinary incontinence: the Personalised Advantage Index as a decision-making aid
Objective To develop a prediction model and illustrate the practical potential of personalisation of treatment decisions between app-based treatment and care as usual for urinary incontinence (UI). Design A prediction model study using data from a pragmatic, randomised controlled, non-inferiority trial. Setting Dutch primary care from 2015, with social media included from 2017. Enrolment ended on July 2018. Participants Adult women were eligible if they had ≥2 episodes of UI per week, access to mobile apps and wanted treatment. Of the 350 screened women, 262 were eligible and randomised to app-based treatment or care as usual; 195 (74%) attended follow-up. Predictors Literature review and expert opinion identified 13 candidate predictors, categorised into two groups: Prognostic factors (independent of treatment type), such as UI severity, postmenopausal state, vaginal births, general physical health status, pelvic floor muscle function and body mass index; and modifiers (dependent on treatment type), such as age, UI type and duration, impact on quality of life, previous physical therapy, recruitment method and educational level. Main outcome measure Primary outcome was symptom severity after a 4-month follow-up period, measured by the International Consultation on Incontinence Questionnaire the Urinary Incontinence Short Form. Prognostic factors and modifiers were combined into a final prediction model. For each participant, we then predicted treatment outcomes and calculated a Personalised Advantage Index (PAI). Results Baseline UI severity (prognostic) and age, educational level and impact on quality of life (modifiers) independently affected treatment effect of eHealth. The mean PAI was 0.99±0.79 points, being of clinical relevance in 21% of individuals. Applying the PAI also significantly improved treatment outcomes at the group level. Conclusions Personalising treatment choice can support treatment decision making between eHealth and care as usual through the practical application of prediction modelling. Concerning eHealth for UI, this could facilitate the choice between app-based treatment and care as usual. Trial registration number NL4948t.
- Open Access
- 31 May 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (9) , 1538-1545
Cost‐effectiveness of an app‐based treatment for urinary incontinence in comparison with care‐as‐usual in Dutch general practice: a pragmatic randomised controlled trial over 12 months
Objective: To assess the cost‐effectiveness of app‐based treatment for female stress, urgency or mixed urinary incontinence (UI) compared with care‐as‐usual in Dutch primary care.Design: A pragmatic, randomised controlled, superiority trial.Setting: Primary care in the Netherlands from 2015 to 2018, follow‐up at 12 months.Population: Women with ≥2 UI‐episodes per week, access to mobile apps, wanting treatment.Methods: The standalone app included conservative management for UI with motivation aids (e.g. reminders). Care‐as‐usual delivered according to the Dutch GP guideline for UI.Main outcome measures: Costs and cost‐effectiveness and ‐utility were assessed from a societal perspective, based on incontinence impact adjusted life years (IIALYs), quality adjusted life years (QALYs) and medical, non‐medical and productivity costs. Information on costs was obtained with the iMCQ and iPCQ questionnaires (medical consumption and productivity cost questionnaires).Results: In all, 262 women were andomised equally to app or care‐as‐usual; 89 (68%) and 83 (63%) attended follow‐up, respectively. Costs were lower for app‐based treatment with € −161 (95% confidence interval [CI −180 to −151) per year. Cost‐effectiveness showed small mean differences in effect for IIALY (0.04) and QALY (−0.03) and thus larger incremental cost‐effectiveness ratios (ICER: −€3696) and incremental cost‐utility ratios (ICUR: €6379).Conclusion: App‐based treatment is a cost‐effective alternative to care‐as‐usual for women with UI in Dutch primary care.Tweetable App‐treatment for female urinary incontinence cost‐effective compared to care‐as‐usual in general practice after 12 months.
- 31 May 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (9) , 1538-1545
Open AccessCost‐effectiveness of an app‐based treatment for urinary incontinence in comparison with care‐as‐usual in Dutch general practice: a pragmatic randomised controlled trial over 12 months
Objective: To assess the cost‐effectiveness of app‐based treatment for female stress, urgency or mixed urinary incontinence (UI) compared with care‐as‐usual in Dutch primary care.Design: A pragmatic, randomised controlled, superiority trial.Setting: Primary care in the Netherlands from 2015 to 2018, follow‐up at 12 months.Population: Women with ≥2 UI‐episodes per week, access to mobile apps, wanting treatment.Methods: The standalone app included conservative management for UI with motivation aids (e.g. reminders). Care‐as‐usual delivered according to the Dutch GP guideline for UI.Main outcome measures: Costs and cost‐effectiveness and ‐utility were assessed from a societal perspective, based on incontinence impact adjusted life years (IIALYs), quality adjusted life years (QALYs) and medical, non‐medical and productivity costs. Information on costs was obtained with the iMCQ and iPCQ questionnaires (medical consumption and productivity cost questionnaires).Results: In all, 262 women were andomised equally to app or care‐as‐usual; 89 (68%) and 83 (63%) attended follow‐up, respectively. Costs were lower for app‐based treatment with € −161 (95% confidence interval [CI −180 to −151) per year. Cost‐effectiveness showed small mean differences in effect for IIALY (0.04) and QALY (−0.03) and thus larger incremental cost‐effectiveness ratios (ICER: −€3696) and incremental cost‐utility ratios (ICUR: €6379).Conclusion: App‐based treatment is a cost‐effective alternative to care‐as‐usual for women with UI in Dutch primary care.Tweetable App‐treatment for female urinary incontinence cost‐effective compared to care‐as‐usual in general practice after 12 months.
- Open Access
- 31 May 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (9) , 1474-1480
One year effectiveness of an app‐based treatment for urinary incontinence in comparison to care as usual in Dutch general practice: A pragmatic randomised controlled trial over 12 months
Objective: To assess the long‐term effectiveness of app‐based treatment for female stress, urgency or mixed urinary incontinence (UI) compared with care‐as‐usual in primary care.Design: A pragmatic, randomised controlled, superiority trial.Setting: Primary care in the Netherlands from 2015 to 2018, follow up at 12 months.Population: Women with two or more UI episodes per week and access to mobile apps, wanting treatment. A total of 262 women were randomised equally to app or care‐as‐usual; 89 (68%) and 83 (63%) attended 1 year follow up.Interventions: The standalone app included conservative management for UI with motivation aids (e.g. reminders). Care‐as‐usual was delivered according to the Dutch GP guideline for UI.Main outcome measures: Effectiveness assessed by the change in symptom severity score (ICIQ‐UI‐SF) and the change in quality of life (ICIQ‐LUTSqol) with linear regression on an intention‐to‐treat basis.Results: Clinically relevant improvement of UI severity for both app (−2.17 ± 2.81) and care‐as‐usual (−3.43 ± 3.6) groups, with a non‐significant mean difference of 0.903 (−0.66 to 1.871).Conclusion: App‐based treatment is a viable alternative to care‐as‐usual for UI in primary care in terms of effectiveness after 1 year.Tweetable App‐based treatment for female urinary incontinence is a viable alternative to care‐as‐usual after 12 months.
- 31 May 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (9) , 1474-1480
Open AccessOne year effectiveness of an app‐based treatment for urinary incontinence in comparison to care as usual in Dutch general practice: A pragmatic randomised controlled trial over 12 months
Objective: To assess the long‐term effectiveness of app‐based treatment for female stress, urgency or mixed urinary incontinence (UI) compared with care‐as‐usual in primary care.Design: A pragmatic, randomised controlled, superiority trial.Setting: Primary care in the Netherlands from 2015 to 2018, follow up at 12 months.Population: Women with two or more UI episodes per week and access to mobile apps, wanting treatment. A total of 262 women were randomised equally to app or care‐as‐usual; 89 (68%) and 83 (63%) attended 1 year follow up.Interventions: The standalone app included conservative management for UI with motivation aids (e.g. reminders). Care‐as‐usual was delivered according to the Dutch GP guideline for UI.Main outcome measures: Effectiveness assessed by the change in symptom severity score (ICIQ‐UI‐SF) and the change in quality of life (ICIQ‐LUTSqol) with linear regression on an intention‐to‐treat basis.Results: Clinically relevant improvement of UI severity for both app (−2.17 ± 2.81) and care‐as‐usual (−3.43 ± 3.6) groups, with a non‐significant mean difference of 0.903 (−0.66 to 1.871).Conclusion: App‐based treatment is a viable alternative to care‐as‐usual for UI in primary care in terms of effectiveness after 1 year.Tweetable App‐based treatment for female urinary incontinence is a viable alternative to care‐as‐usual after 12 months.